Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


Caroline Relton obtained a PhD in molecular genetics at Newcastle University in 1999 where she then held an academic position for 12 years, before moving to the University of Bristol in 2012. Caroline’s research focuses on understanding the role of both genetic and epigenetic variation in development and disease. The work of her group includes using population-based approaches to study epigenetic information as a biomarker of exposure and a predictor of disease. She has developed and applied causal analysis methods to understand the role of epigenetic processes as disease mechanisms and has led studies investigating the genetic architecture of DNA methylation variation. Her research spans multiple clinical areas from perinatal health to cancer. Caroline is also Director of the Bristol Population Health Science Research Institute.

This lecture will provide some background as to why the fusion of epigenetics and epidemiology may be a fruitful avenue of enquiry in biomedical research, what sorts of questions we can consider addressing, what some of the challenges are and describe some of the solutions that we have developed.

Forthcoming events

Richard Doll Seminar - Adventures in Digital Health Research: Alcohol, Coffee, and Arrhythmias

Tuesday, 03 September 2024, 1pm to 2pm @ Richard Doll Lecture Theatre, Richard Doll Building, OldRoad Campus, University of Oxford, OX3 7LF